BON
News
Announced NextGen of Tea Pigment Digestive Health Products and Cooperation Agreement of US26 Million with Beijing Huahai Keyuan
Agreement
2025-11-25 16:43:34
SLXN
News
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204 NextGeneration RNA Silencing Therapy Ahead of Phase 23 Clinical Trial in Pancreatic Cancer
FDAPhase 2
2025-11-25 16:16:34
TRNR
News
Maturity Date Extended Interactive Strength Inc extended the maturity date of its Exchange Note from to on The Exchange Note is part of a 20 million agreement involving senior secured convertible notes and
Agreement
2025-11-25 16:15:32
LMT
News
Space Force is said to award contracts for Golden Dome interceptors
2025-11-25 16:05:29
ATAI
News
HC Wainwright Maintains Buy on Atai Beckley ATAI Following Breakthrough Therapy and Merger Completion
2025-11-25 15:42:23
TLSA
News
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
FDAPhase 2
2025-11-25 15:33:34
GLXZ
News
Galaxy Gaming Evolution extend merger agreement outside date
Agreement
2025-11-25 15:10:17
STAI
News
News ScanTech AI Systems and unival group GmbH Announce Strategic Partnership to Expand Security Technology Deployments Across Europe the Middle East and Africa
2025-11-25 15:02:58
HTOO
News
Fusion Fuels BrightHy Solutions Expands Green Hydrogen Footprint in Southern Europe with Agreement to Deliver New Electrolyzer and Hydrogen Refueling Station Project
Agreement
2025-11-25 14:33:07
BCTX
News
BriaCell to Highlight Positive Phase 2 Phase 3 Clinical Data at SABCS
FDAPhase 3
2025-11-25 14:32:34
RAPP
News
Rapport Therapeutics to Present New Phase 2a Data Analysis Further Characterizing RAP219 in Focal Onset Seizures at 2025 American Epilepsy
FDAPhase 2
2025-11-25 14:07:45
KYMR
News
Kymera Therapeutics announces first patient dosed in BROADEN2 Phase 2b trial
FDAPhase 2
2025-11-25 14:04:18
VLTO
News
Veralto Announces Agreement to Acquire InSitu and Establishes 750 Million Share Repurchase Program
Agreement
2025-11-25 14:02:16
Trading Ideas Platform
Your comprehensive source for market intelligence and trading opportunities. Track IPOs, breaking news, and political developments that impact financial markets. Get real-time insights, phase updates, and FDA announcements to make informed trading decisions. Stay ahead of market movements with our curated analysis and timely alerts.